RGC 股價走勢圖
RGC 收益
Regencell Bioscience Holdings Ltd
$0
0%
$0
收盤價：Apr 27, 16:00:00 GMT-4
$0
0%
$0
盤後：Apr 27, 17:34:08 GMT-4
返回
Regencell Bioscience Holdings Ltd (RGC) 收益
關鍵數據
前收市價
--
開盤價
--
當日範圍
-
52週區間
-
交易量
--
平均成交量
248.8K
股息收益率
--
每股盈餘 (TTM)
-0.01
市值
--
什麼是 RGC？
Regencell Bioscience Holdings Ltd. is a early-stage bioscience company that focuses on research, development and commercialization of Traditional Chinese Medicine for the treatment of neurocognitive disorders and degeneration, specifically Attention Deficit Hyperactivity Disorder and Autism Spectrum Disorder. The company employs 12 full-time employees The company went IPO on 2021-07-16. The firm launches three liquid based standardized TCM formulae candidates for mild, moderate and severe ADHD and ASD patients.